by Maria Zannes | Nov 15, 2016 | Press Releases
NOVEMBER 15, 2016 (SAN ANTONIO, TX) bioAffinity Technologies announced that the government of the Hong Kong Special Administrative Region has awarded a Certificate of Grant of Standard Patent for the Company’s proprietary CyPath© technology for the early detection of...
by Maria Zannes | Aug 25, 2016 | Articles, News
AUGUST 25, 2016 As published in the San Antonio Business Journal By W. Scott Bailey City Council authorized the San Antonio Economic Development Corporation on Thursday to directly invest in bioAffinity Technologies. It’s another indication that City Hall is...
by Maria Zannes | Aug 24, 2016 | Press Releases
AUGUST 24, 2016 (SAN ANONIO, TX) bioAffinity Technologies today announced that it has been awarded a U.S. Patent protecting a proprietary kit that contains the CyPath® assay for the early detection of cancer and the prognosis of the patient response to cancer therapy....
by Maria Zannes | Jul 13, 2016 | News
JULY 13, 2016 As published in the San Antonio Business Journal By W. Scott Bailey One of San Antonio’s more promising bioscience companies, bioAffinity Technologies Inc., has locked up a key deal, renewing its collaborative agreement with the University of Texas...
by Maria Zannes | Jul 13, 2016 | Press Releases
JULY 13, 2016 (SAN ANTONIO, TX) bioAffinity Technologies today announced the renewal of its collaborative agreement with The University of Texas Health Science Center at San Antonio for research and development of novel cancer diagnostic and therapeutic agents using...